AT253696B - Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung - Google Patents

Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung

Info

Publication number
AT253696B
AT253696B AT336263A AT336263A AT253696B AT 253696 B AT253696 B AT 253696B AT 336263 A AT336263 A AT 336263A AT 336263 A AT336263 A AT 336263A AT 253696 B AT253696 B AT 253696B
Authority
AT
Austria
Prior art keywords
steroids
preparation
double bond
bond
double
Prior art date
Application number
AT336263A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of AT253696B publication Critical patent/AT253696B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
AT336263A 1962-04-25 1963-04-25 Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung AT253696B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR895563A FR1380415A (fr) 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10)

Publications (1)

Publication Number Publication Date
AT253696B true AT253696B (de) 1967-04-25

Family

ID=8777621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT336263A AT253696B (de) 1962-04-25 1963-04-25 Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung

Country Status (7)

Country Link
AT (1) AT253696B (de)
BR (1) BR6348576D0 (de)
CH (1) CH414609A (de)
DK (1) DK105336C (de)
ES (1) ES287334A1 (de)
FR (2) FR1380415A (de)
GB (1) GB1015013A (de)

Also Published As

Publication number Publication date
FR2323M (fr) 1964-02-10
FR1380415A (fr) 1964-12-04
GB1015013A (en) 1965-12-31
CH414609A (fr) 1966-06-15
BR6348576D0 (pt) 1973-07-03
DK105336C (da) 1966-09-19
ES287334A1 (es) 1963-07-16

Similar Documents

Publication Publication Date Title
CH500182A (de) Verfahren zur Herstellung von Cardenolid-tridigitoxosid-acylaten
AT253696B (de) Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung
AT242863B (de) Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen
CH419112A (de) Verfahren zur Herstellung von 16 B-Alkylthio-17 B-hydroxy-steroiden
AT244328B (de) Verfahren zur Herstellung von Sulfamylanthranilsäuren
CH426792A (de) Verfahren zur Herstellung von 9(11)-Dehydro-12-desoxy-steroiden
AT250582B (de) Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden
CH427812A (de) Verfahren zur Herstellung von Oxathiazolinonen
CH415651A (de) Verfahren zur Herstellung von 3-Aryl-4-halogen-pyridazonen-(6)
CH460764A (de) Verfahren zur Herstellung von 6-Alkylsteroiden
AT313490B (de) Verfahren zur Herstellung von 18-Methylensteroiden
CH418323A (de) Verfahren zur Herstellung von w-Halogen-alkylaminen mit einer Dreifachbindung
CH484140A (de) Verfahren zur Herstellung von 2-Oxo-7-phenyl-1,2,3,4,6,7-hexahydro-11bH-benzo(a)chinolizinen
AT270608B (de) Verfahren zur Herstellung von 3-Ketobutanol-(1)
CH428721A (de) Verfahren zur Herstellung von 4'-Monoacyl-cymarol
CH435313A (de) Verfahren zur Herstellung von 4-Methyl-6-(2-formyl-propen-1-yl)-pyron-(2)
AT257064B (de) Verfahren zur Herstellung von 16α-Hydroxysteroiden
AT242149B (de) Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin
CH420128A (de) Verfahren zur Herstellung von 6a- bzw. 6B-Niederalkanoylthio-4-en-3-on-steroiden
CH456599A (de) Verfahren zur Herstellung von Thiazolnitroaniliden
CH482659A (de) Verfahren zur Herstellung von 17-Äthyliden-Steroiden
CH515229A (de) Verfahren zur Herstellung von 14B-Hydroxy-3-keto-5B-card-20(22)-enoliden
CH409978A (de) Verfahren zur Herstellung von 1-Aryl-hydropyrazolen
AT253139B (de) Verfahren zur Herstellung von Aminosteroiden
CH437270A (de) Verfahren zur Herstellung von 10-Formylsteroiden